Figure 4
From: B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy
Effect of siRNAGAPDH on the expression levels of GAPDH. A20 cells were treated with siRNAGAPDH and peptide-siRNAGAPDH complexes for 48 hours. After incubation cell extracts were analyzed by western blot with anti-GAPDH antibody. A. Lanes: 1, control; 2, siRNAGAPDH; 3, siRNASCR; 4, A20-36-9R; 5, A20-36-9R-siRNAGAPDH; 6, A20-36-9R-siRNASCR; 7, 5R-A20-36-5R; 8, 5R-A20-36-5R-siRNAGAPDH; 9, 5R-A20-36-5R-siRNASCR. B. Lanes: 1, Control; 2, RND-9R; 3, RND-9R-siRNAGAPDH; 4, RND-9R-siRNASCR; 5, 5R-RND-5R; 6, 5R-RND-5R-siRNAGAPDH; 7, 5R-RND-5R-siRNASCR. Data are from three experiments are reported as the mean ± SD. * p < 0.05 compared to control and to all other samples.